Promacta and Centrum silver drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Promacta (eltrombopag olamine) and Centrum silver (ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e). Common drug interactions include visual impairment among females and atrial fibrillation among males.

The phase IV clinical study analyzes what interactions people have when they take Promacta and Centrum silver. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Promacta?

Promacta has active ingredients of eltrombopag olamine. It is often used in idiopathic thrombocytopenic purpura (itp). eHealthMe is studying from 17,758 Promacta users. Check the latest studies of Promacta.

What is Centrum silver?

Centrum silver has active ingredients of ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e. It is often used in vitamin supplementation. eHealthMe is studying from 19,997 Centrum silver users. Check the latest studies of Centrum silver.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 23, 2026

15 people who take Promacta and Centrum silver together, and have interactions are studied.

Promacta and Centrum silver drug interactions.

What are the common drug interactions of Promacta and Centrum Silver, by gender? *:

female:

  1. Visual impairment
  2. Vitreous floaters (spots before the eyes)
  3. Headache (pain in head)
  4. Diarrhoea
  5. Pain in extremity
  6. Visual acuity reduced (reduced clearness of vision)
  7. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  8. Back pain
  9. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  10. Bone marrow plasmacyte count increased

male:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Fall
  3. Fluid overload (too much fluid in the blood)
  4. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  5. Haemorrhage (bleeding)
  6. Hospitalisation
  7. Hypertension (high blood pressure)
  8. Hypotension (abnormally low blood pressure)
  9. Injury
  10. Ligament sprain (ligament stretched)

What are the common drug interactions of Promacta and Centrum Silver, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Tremor (trembling or shaking movements in one or more parts of your body)
  2. Weight decreased
  3. Ageusia (loss of taste functions of the tongue)
  4. Asthenia (weakness)
  5. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  6. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  7. Compression fracture (fracture due to pressure caused by injury)
  8. Decreased appetite
  9. Dry mouth
  10. Dysgeusia (disorder of the sense of taste)

50-59:

n/a

60+:

  1. Diarrhoea
  2. Headache (pain in head)
  3. Back pain
  4. Bacteraemia (presence of bacteria in the blood)
  5. Bacterial test positive
  6. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  7. Bone marrow plasmacyte count increased
  8. Bone marrow reticulin fibrosis (thickening and scarring of bone marrow reticulin)
  9. Cardiac murmur (an heart sound in valve abnormality)
  10. Constipation

What are the existing conditions these people have? *

  1. Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 4 people, 26.67%
  2. Zinc Deficiency: 1 person, 6.67%
  3. Thrombocytopenia (decrease of platelets in blood): 1 person, 6.67%
  4. Multiple Myeloma (cancer of the plasma cells): 1 person, 6.67%
  5. Kidney Stones: 1 person, 6.67%
  6. Joint Pain: 1 person, 6.67%
  7. Intestinal Obstruction: 1 person, 6.67%
  8. Insomnia (sleeplessness): 1 person, 6.67%
  9. Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 1 person, 6.67%
  10. High Blood Pressure: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Promacta and Centrum silver?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Promacta and Centrum silver:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Promacta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Centrum silver:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Promacta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Centrum silver and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on eltrombopag olamine and ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e (the active ingredients of Promacta and Centrum silver, respectively), and Promacta and Centrum silver (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: